Abstract-The distribution of echocardiographic left ventricular (LV) mass differs among ethnicities. Because ethnic-specific echocardiographic criteria for LV hypertrophy (LVH) are not established, we determined whether threshold values derived from overwhelmingly white populations are appropriate for blacks, a subgroup having more LVH. Between 1992 and 1994, LV mass was measured echocardiographically in the Jackson, Mississippi, black cohort of the Atherosclerosis Risk in Communities study. Participants free of prevalent cardiovascular disease (CVD) (nϭ1616; meanϮSD, age 59Ϯ5.7; 65% women and 57% with hypertension) were included. The optimal LVH threshold value was selected from the continuum of LV mass index (LVMIϭLV mass/height 2.7 ) using 3 methods: (1) the best operating point from the area under the resulting receiver-operating characteristic (ROC) curve predicting incident CVD; (2) the value with the smallest probability value associated with incident CVD; and (3) visual inspection of functions of LVMI and CVD in the general additive model (GAM) plot. At a median follow-up of 6.8 years, there were 192 events (coronary heart diseaseϭ87, strokeϭ62, and congestive heart failureϭ43; incidenceϭ17.6/1000 person-years). The best operating point from the resulting ROC analysis was 51.2 g/m 2.7 for sensitivity (53.4%) and specificity (61.5%). The Cox and GAM models adjusted for age, gender, systolic blood pressure, hypertension, diabetes, smoking, total cholesterol-to-high-density lipoprotein ratio, LVH by ECG criterion, and socioeconomic status found 50 to 51 g/m 2.7 as the optimal threshold for LVH in middle-aged blacks, corresponding to a minimum probability value and to a log-hazard ratio of zero, respectively. Because these values are close to the 51 g/m 2.7 established from predominantly white populations, this cutpoint is appropriate for both groups. (Hypertension. 2005;45:1-6.) Key Words: epidemiology Ⅲ population Ⅲ echocardiography Ⅲ hypertrophy Ⅲ blacks L eft ventricular hypertrophy (LVH) detected by echocardiography is a precursor of premature mortality across all genders, races, and ages, 1-6 beyond the prognostic significance of alterations in LV geometry 7 and/or electrocardiographic patterns of LVH. 8 Moreover, regression of LVH is a favorable prognostic marker independent of treatmentinduced reduction in blood pressure. 9 LVH has traditionally been determined as the upper 2.5 to 5 percentiles of LV mass index (LVMI) in a reference population. 10 -15 However, it is known that LVMI does not have a Gaussian distribution; thus, the normal range may not contain 95% of the values. Therefore, some authors 16,17 have advocated using a risk factor-driven cutpoint as the optimal approach to dichotomize a continuous diagnostic test. Because LVH prevalence 12,15,18 -20 and incidence of morbid events 21 varies depending on the threshold selected, it is advisable to determine if thresholds obtained from one population apply to others.
L eft ventricular hypertrophy (LVH) detected by echocardiography is a precursor of premature mortality across all genders, races, and ages, [1] [2] [3] [4] [5] [6] beyond the prognostic significance of alterations in LV geometry 7 and/or electrocardiographic patterns of LVH. 8 Moreover, regression of LVH is a favorable prognostic marker independent of treatmentinduced reduction in blood pressure. 9 LVH has traditionally been determined as the upper 2.5 to 5 percentiles of LV mass index (LVMI) in a reference population. 10 -15 However, it is known that LVMI does not have a Gaussian distribution; thus, the normal range may not contain 95% of the values. Therefore, some authors 16, 17 have advocated using a risk factor-driven cutpoint as the optimal approach to dichotomize a continuous diagnostic test. Because LVH prevalence 12,15,18 -20 and incidence of morbid events 21 varies depending on the threshold selected, it is advisable to determine if thresholds obtained from one population apply to others.
To date, LVH thresholds have been derived from overwhelmingly white populations (Table 1 ) and applied to other ethnic groups. 5, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Because ethnic groups differ in anthropometric measures that correlate with heart size, 33 ethnicspecific criteria for LVH may be warranted. The aim of this study is to determine the optimal threshold for LVMI to define LVH in a middle-aged black American population.
Methods
Methods are described in detail in the online supplement available at http://www.hypertensionaha.org.
Study Population
An echocardiographic examination 34, 35 was performed in blacks aged 51 to 70 years from Jackson, Mississippi. After excluding ineligible participants, 570 men and 1046 women were included.
Echocardiography
The echocardiograph protocol has been reported. 34, 35 The reliability assessment of the Atherosclerosis Risk in Communities Study (ARIC) echocardiographic reading center reported intraobserver coefficients of variation of 4.6% for interventricular septum, 4.6% for posterior wall, 1.5% for internal diameter, and 6.3% for LV mass.
Echocardiography Measurements
LV measurements were taken according to the American Society of Echocardiography recommendations. 36 LV mass was calculated according to Devereux's validated formula. 37, 38 As recommended, 13 LV mass values were normalized by height 2.7 to correct for body size differences. The online supplement also contains LV mass values normalized to body surface area (BSA).
Risk Factors Measurements and Definition of Variables
Risk factors were measured at the echocardiographic examination visit using standardized methods. See Table I , available online, for definitions and measurement procedures.
Ascertaining Incident Cardiovascular Disease Events
Coronary heart disease (CHD) and stroke incidence were ascertained by annual contact, identifying hospitalizations and deaths during the previous year, and surveying discharge lists from local hospitals and death certificates for potential events. 39 -41 For participants with no event, follow-up continued until noncardiovascular death (nϭ62), December 31, 2001 , or date of last contact (nϭ1). The median follow-up was 6.55 years (interquartile range, 6.13 to 7.51 years).
Statistical Analysis
Comparisons between genders were performed with Mann-Whitney 2-sample statistic for continuous variables and 2 or Fisher exact test for discrete variables.
We followed a 3-step approach to determine the optimal criterion for LVH: 16 (1) we used Cox regression analysis to quantify the association between LVMI and incident cardiovascular disease (CVD); (2) we created a general additive model (GAM) 42 with Cox extension to uncover the underlying relationship between LVMI and the composite CVD endpoint (Figure 1 ). We also plotted sensitivity (Se) against 1Ϫspecificity (Sp) of each value in the continuum of LVMI (Figure 2 ). The resulting receiver-operating characteristic (ROC) curve 43 provided a full range of diagnostic thresholds for all possible combinations of Se and Sp; and (3) all values suggested by the exploratory plots were examined as candidates for optimal cutpoints. Once the range of values of LVMI was selected (45 to 53 g/m 2.7 ), Cox proportional hazard regression models were used to determine the value associated with a minimum probability value or maximum 2 statistic. 16, 44 Univariate and risk factor-adjusted estimates were computed.
Figure 1.
Optimal LV mass index threshold suggested by GAM plot. In the panel marked "univariate," the functional form in the association between LVMI and the hazard rate for CVD is displayed. In the "multivariate" plot, this association is adjusted simultaneously by age, gender, systolic blood pressure, hypertension, diabetes, status, total cholesterol-to-high-density lipoprotein cholesterol ratio, LVH by ECG, and education level. The dotted curves indicate Ϸ95% CIs for the smoothed hazard. 
Gaussian Distribution Method
We computed a threshold value corresponding to the 95th percentile of LVMI in a subset of apparently healthy individuals.
Single or Gender-Specific Threshold
To further evaluate the generalizability of the threshold for both sexes, the interaction term of LVH (with a 50 g/m 2.7 threshold) with gender was tested in the multivariate analysis, and the value of LVMI corresponding to a log-hazard ratio (HR) of 0 in the GAM curves, in men and women, was also examined.
Results

Clinical and Echocardiographic Findings
Clinical characteristics of the study population are presented online in Table II . Echocardiographic variables are presented in Table 2 .
LV mass was higher in men, a difference that disappeared when it was indexed by height 2.7 (Pϭ0.08). The prevalence of LVH varied from 40% to 50% in women, but not in men (36%), depending on the criteria used. When using the single partition value currently in use (50 g/m 2.7 ), the difference in LVH prevalence by gender (Pϭ0.05) is attenuated, when compared with the gender-specific criteria, in which women had a greater prevalence than men (PϽ0.001).
Outcomes and Crude Rates
At the median follow-up, a total of 192 events were identified (Table 3) . Under the Poisson assumption, an event rate of 17.6 per 1000 person-years was calculated for the entire population, but men had significantly higher rates than women (25.4 versus 13.4 per 1000 person-years; PϽ0.001). Figure 1 displays the GAM plots. No differences in the optimal threshold were seen between univariate and the multivariate models. Visual inspection of the graph showed that CVD risk increased steadily as LVMI increased, therefore rejecting the null hypothesis of nonlinearity for LVMI ( 2 ϭ4.10; dfϭ4.84; Pϭ0.37). The curve also identified 51 g/m 2.7 to be the value of LVMI when the corresponding hazard rate for CVD was zero. Figure 2 shows sensitivity and specificity curves plotted along a range of LVMI values given the reference test (incident CVD); the optimal threshold estimated by the point where the curves cross was 51. Table  III shows that LVH with a threshold at 50 g/m 2.7 (Pϭ0.083) best-separated subjects' outcomes by the minimum probability value approach. The interaction term of LVH with gender was not significant in any of the models tested. As supportive evidence, the same threshold chosen by the adjusted minimum probability value was associated with the highest area under the curve (0.744), indicating the multivariate model defining LVH at 50 g/m 2.7 had the highest discriminatory ability for future CVD events. Similar trends in the results from univariate analyses were found after adjusting by multiple comparisons (results not shown). Table 4 depicts the characterization of the LVH modeled as a dichotomous screening test in terms of true and false-positive rates, positive predictive value (PPV) and negative predictive value (NPV), and likelihood ratio (LR). Our criterion for LVH was associated with a sensitivity of 57.1% and specificity of 60.8%. Regarding how accurately LVH predicts future CVD events, the calculated PPV and NPV were 13.3% and 93.1%, respectively.
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Demographic and clinical characteristics of the apparently healthy population are displayed in Table II ; echocardiographic characteristics are in Table 2 . The computed 95th percentile of LVMI was 52.9 g/m 2.7 (95% CI, 50.1 to 55.7).
BSA-Normalized Cutpoint
To allow comparison with other studies, the online supplement ( Figure I ) shows the GAM plot and sensitivity and specificity curves for BSA-normalized LV mass index. The optimum threshold for BSA-LVH was 105 g/m 2 . 
Discussion
To our knowledge, this is the first report that determined echocardiographic LVH thresholds in blacks. Previous studies that have focused on comparing black and white patients, or a few of them performed exclusively in blacks, have used the thresholds derived from whites. 10 -15 This was performed despite caution raised by the authors regarding the lack of validation with other ethnic groups. 10 -12,14 Using the approach recommended by Mazumdar et al, 16 our results point to 50 g/m 2.7 as the optimal threshold selected on multivariate setting, which is the value that minimizes the probability value relating LVH to cardiovascular disease. This threshold value was further supported by the generalized additive model analysis, which showed graphically that 51 g/m 2.7 was the point that the GAM curve crossed a hazard rate of 0, and by the finding that the best operating point derived from the area under the curve points toward a similar value. To make our results comparable with previous studies, 10 -15 we also estimated the 95th percentile of LVMI values in our reference subpopulation. Our results based in the percentile method (a single threshold at 52.9 g/m 2.7 ) were slightly higher than previous LVH criteria 10 -15 and our prognostically driven estimates. We speculate that differences in exclusion criteria applied as well as the ethnic composition of the reference population in which the criteria were estimated may play an important role. For example, Devereux et al 22 used a reference population from 2 different sources, hospital-based series and employed adults, and de Simone et al 13, 20 from 3 normotensive populations (in New York City; Naples, Italy; and Cincinnati, Ohio), and no mention is made in those studies about the proportion of blacks. The composition of the reference population from the Framingham study is predominantly white. 12, 14 Nonetheless, the confidence intervals associated with the 95th percentile of LVMI in our analysis included the threshold value estimated by endpoint-driven methods.
Single Threshold for Both Genders
It has been unclear whether gender-specific threshold values are needed to define LVH. For the sake of simplicity, previous investigators 11, 13, 22 have proposed a unique partition value typically estimated by a prespecified percentile and then validated prognostically against morbid CHD events. 1, 20 To determine the generalizability of the single threshold computed on our cohort, we tested the interaction between LVH and gender in the Cox model. Because no differences were found (Pϭ0.814), our findings support a common threshold of 50 g/m 2.7 for both genders. Likewise, a common threshold was supported by visual inspection of the GAM curves, calculated separately in each gender (results not presented).
Characteristics of LVH as a Diagnostic Tool
Relative performance of LVH defined by our single criterion may be evaluated using 2 dimensions of the accuracy scale, namely disease-specific classification probabilities (true positive rate) and false-positive rate, predictive values (PPV and NPV), and diagnostic likelihood ratios (LR ϩ and LR Ϫ ). Using our criterion, a TPR of 57.1% and an false-positive rate of 39.2% means testing positive for LVH misses 42.9% of the subjects in whom CVD developed at follow-up and incorrectly identified 39.2% of low-risk subjects as being at high risk for future events. In regard to how well LVH predicted future CVD events, a PPV of 13.3% indicates that among subjects that test positive for LVH, only a few of them had events in the 8-year follow-up period. A NPV of 93.1% showed that only 6.9% of subjects that tested negative were at risk for future events. The likelihood ratios associated with our proposed threshold were: LR ϩ ϭ1.46 (1.28 to 1.67) and LR Ϫ ϭ0.71 (0.60 to 0.83). However, the pretest odds of disease, 0.105, were increased to 0.153 by a positive test, and this was decreased to 0.074 by a negative test. Further discussion of the usefulness of LVH as a diagnostic tool is included in the online supplement (Table V, Figure II , and comments).
Limitations of the Study
First, the threshold derived here has been tested only in the data set from which it was derived; it has not been prospectively validated with independent data or in another cohort of blacks. Second, the validity of our results is limited to a CVD-free population of blacks. Third, the lack of a longitudinal assessment of LV mass did not permit us to account for the effects of serial changes in LV mass that may be associated with the incidence of CVD events. Although our threshold for blacks is the same as that recommended generally, we cannot extrapolate this finding to other ethnic groups. Therefore, we recommend future research be performed to establish ethnic-specific LVH thresholds for other groups.
Herman Taylor and Michael Andrew
Online supplement for
Optimal threshold value for left ventricular hypertrophy in AfricanAmericans: the ARIC study Nunez An echocardiographic examination 3, 4 was performed (1992 through 1994) in African Americans age 51-70 years from Jackson, Mississippi. Participants were selected by probability sampling. After excluding subjects with technically inadequate echocardiograms, valvular heart disease, LV wall motion abnormalities, ventricular aneurysm, severely depressed LV function, and prevalent coronary heart disease (CHD), 570 men and 1046 women were included in this analysis. Echocardiography The echocardiograph protocol has been reported. 3, 4 In brief, M-mode tracings and measurements of the LV were performed under two-dimensional guidance. Tracings were read by one of two cardiologists, and the average of three measurements was computed. The reliability assessment of the ARIC echocardiographic reading center reported intraobserver coefficients of variation of 4.6% for interventricular septum, 4.6% for posterior wall, 1.5% for internal diameter, and 6.3% for LV mass. Echocardiography measurements LV measurements were taken according to the American Society of Echocardiography recommendations. 5 LV mass was calculated according to Devereux's validated formula. 6, 7 As recommended, 8 LV mass values were normalized by height 2.7 to correct for body size differences.
Risk factors measurements and definition of variables
Risk factors were measured at the echocardiographic exam visit using standardized methods. See Table I in this online supplement for definitions and measurement procedures. Ascertaining incident CVD events CHD and stroke incidence were ascertained by annual contact, identifying hospitalizations and deaths during the previous year, and surveying discharge lists from local hospitals and death certificates for potential events. 1,9,10 CHD incidence was defined as hospitalization for myocardial infarction (MI), cardiac death, or revascularization procedure, or by electrocardiogram (ECG) changes between baseline and follow-up examinations. 1 Definite or probable MI was based on a combination of chest pain, evolving electrocardiographic changes, and levels of cardiac enzymes. 1, 10 Stroke included ischemic as well as hemorrhagic stroke. Heart failure was defined by hospital discharge diagnosis. For participants with a verified clinical event, follow-up time was calculated between the echocardiogram and date of the first event. For participants with no event, follow-up continued until non-cardiovascular death (n=62), 31 December 2001 (n=1405), or date of last contact (n=1). The median follow-up was 6.55 years (interquartile range 6.13-7.51 years).
Statistical analysis
Comparisons between genders were performed with Mann-Whitney two-sample statistic for continuous variables and chi-square or Fisher's exact test (2x2 tables) for discrete variables. All statistical analyses were performed using Stata 8.2 (StataCorp, College Station, TX).
We followed a three step approach to determine the optimal criterion for left ventricular hypertrophy (LVH) 11 :
Identify continuous prognostic variable in appropriate regression setting
We used Cox regression analysis to quantify the association between left ventricular mass index (LVMI) and incident CVD after graphically assessing the proportional hazards assumption.
Create exploratory plots and look for patterns a. Generalized Additive Model (GAM)
We used GAM 12 with Cox extension to uncover the underlying relationship between LVMI and the composite CVD endpoint. By plotting smoothed LVMI functions versus the hazard rate for CVD, we selected the value along the continuum of LVMI corresponding to a hazard rate of zero as the optimal threshold (Figure 1 in  print version) .
b. Area under the curve (AUC)
The ability of the LVMI to discriminate between low-high probabilities of CVD events was assessed by plotting sensitivity (Se) against 1-specificity (Sp) of each value in the continuum of LVMI (Figure 2 in print version) . The resulting receiver operating characteristic (ROC) curve 13 provided a full range of diagnostic thresholds for all possible combinations of Se and Sp. Confidence intervals for the AUC were estimated using bootstrapping resampling with 1000 simulations and using the exact binomial method.
Perform systematic search
All values suggested by the exploratory plots were examined as candidates for optimal cutpoints. Once the range of values of LVMI was selected (45-53 g/m 2.7 ), Cox proportional hazard regression models were used to determine the value associated with a minimum P-value or maximum chi-square statistic. 11, 14 Univariate as well as risk factor-adjusted (age, gender, systolic blood pressure, hypertension, diabetes, total cholesterolhigh density lipoprotein cholesterol ratio, smoking status, LVH by ECG criterion, and level of education greater than high school) estimates were computed. As an ancillary criterion for model selection, C statistics (or AUC) were estimated from the multivariate Cox regression analyses to characterize them by their discriminatory capacity.
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Gaussian distribution method
We computed a threshold value corresponding to the 95 th percentile of LVMI in a subset of apparently healthy individuals (i.e., excluding subjects with diabetes, overweight/obese, abdominal obesity, hypertension, and those receiving any cardioactive drug).
Single or gender-specific threshold
To further evaluate the generalizability of the threshold for both sexes, the interaction term of LVH (with a 50 g/m 2.7 threshold) with gender was tested in the multivariate analysis, as well as looking at the value of LVMI corresponding to a log hazard ratio of 0 in the GAM curves, in men and women. 
LVH as a predictor of CVD
In evaluating a biomarker as a predictor for cardiovascular risk, several conditions must be met to establish its prognostic utility; chief among these is the strength and duration of the association between biomarker and outcome. With this in mind, we sought to determine the performance of LVH at different time points of follow-up, in terms of strength of the association with CVD (measured as hazard ratio (HR)), discriminative performance (measured as area under the curve (AUC) and Brier Score), and predictive accuracy (measured as likelihood ratios (LR+ and LR-)). Table V shows a degradation of the prognostic value of LVH as followup time increases. The hazard ratio is below 2.00 which indicates LVH is a modest predictor for CVD. Competing components of the composite risk analysis. The performance of LVH as a diagnostic tool is also a function of our composite endpoint. This figure shows the cumulative incidence of endpoint components CHD, CHF, and stroke. LVH is a powerful predictor for stroke and CHF but not for incident CHD. By broadening the nominal endpoint to include CHD, we effectively lowered the predictive value of LVH.
